New Hampshire Clinical Trials Report — May 2026

For New Hampshire residents considering participation in clinical research, May 2026 brings an important message: act quickly for several studies nearing their enrollment deadlines. Across the state, 19 clinical trials are scheduled to close within the next 90 days. This includes opportunities for healthy volunteers, with 2 of these rapidly closing studies actively seeking participants without specific health conditions. If you've been thinking about contributing to medical advancements, now is a crucial time to explore these options before they are no longer available.

Patients managing certain health conditions also have limited time to join research. Trials focused on specific types of cancer, trauma, and heart conditions are among those with impending deadlines for enrollment. Conditions with trials closing soon include:

• Stage IV lung cancer
• Trauma injury
• Advanced lung non-small cell carcinoma
• Anatomic stage III breast cancer
• Breast cancer
• Chronic granulomatous disease (CGD)
• Early stage breast cancer
• Congenital heart disease
• Fracture infection
• Hearing loss

These studies represent a chance to access potential new treatments or contribute to understanding these conditions. We encourage interested individuals to review eligibility criteria promptly.

A Look at New Research Opportunities

This month, New Hampshire saw the opening of 1 new clinical trial, a notable shift compared to the 4 trials that launched in March 2026. While the number of new openings is lower this month, this single new study offers a unique opportunity, particularly for healthy volunteers and older adults.

The new trial, sponsored by American Laboratory Products Company, is a device study focused on:

• Healthy volunteers
• Vitamin D deficiency
• Vitamin D insufficiency

This study is actively seeking participants, including older adults, and represents an industry-led effort to advance medical devices. It offers a chance for individuals without specific health conditions to contribute to research, which is vital for establishing baseline data and understanding how new technologies perform in a general population.

Participation for Healthy Volunteers and Diverse Demographics

New Hampshire continues to offer avenues for a wide range of participants. The single new trial launched this month is open to healthy volunteers, providing an accessible entry point into clinical research for those without specific medical conditions. Statewide, a total of 26 clinical trials are currently recruiting healthy participants, offering numerous ways to contribute to scientific discovery.

The new trial also includes older adults in its eligibility criteria, ensuring that senior populations have opportunities to engage in research that could directly benefit their age group. This focus on diverse demographics helps ensure that new treatments and devices are evaluated across the populations they are intended to serve.

New Hampshire's Research Footprint

New Hampshire's clinical research landscape remains active, with a total of 319 clinical trials currently recruiting across 19 cities and 113 research sites. This broad distribution ensures that research opportunities are available throughout the state, not just concentrated in major metropolitan areas.

This month's new trial is located in Salem, expanding the geographic reach of new research initiatives. While we didn't see a cluster of new trials in a single city this month, the overall number of sites and cities involved in research underscores New Hampshire's commitment to advancing medical science across its communities.

Looking ahead, we anticipate continued growth in research opportunities across New Hampshire, with a focus on diverse health challenges and innovative solutions. We encourage all interested individuals to stay informed about upcoming trials and consider how their participation can make a difference in the future of healthcare.